Federica Pacchini
University of Pisa
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Federica Pacchini.
Farmaco | 2002
Giuliana Biagi; Irene Giorgi; Oreste Livi; Federica Pacchini; Pietro Rum; Valerio Scartoni; Barbara Costa; Maria Rosa Mazzoni; Laura Giusti
erythro-2-Phenyl-9-(2-hydroxy-3-nonyl)adenine and its 8-aza analog were prepared and showed a very high inhibitory activity towards adenosine deaminase (ADA), with Ki 0.55 and 1.67 nM, respectively, and high affinity for A1 adenosine receptors, with Ki 28 and 2.8 nM, respectively. To increase affinity for A1 receptors we introduced a substituent on the N6 position such as alkyl or cycloalkyl groups, which are present in effective agonists or antagonists. Furthermore, for some compounds, we prepared the two diastereoisomers erythro and threo to verify whether the binding with A1 receptors is stereoselective, as in ADA. Results show that some of the synthesised compounds are good inhibitors for ADA and good ligands for A1, and the erythro diastereoisomers are more active than the threo ones. The experimental evidence allows us to hypothesise some similarity in the three dimensional structures of the binding site of the two proteins, ADA and A1 adenosine receptor, in spite of lacking any homologies in the amino acid sequences.
Farmaco | 2001
Giuliana Biagi; Irene Giorgi; Federica Pacchini; Oreste Livi; Valerio Scartoni
The title compounds were prepared and tested as xanthine oxidase (XO) inhibitors. Results evidenced that potency was related to the position of the oxygen atom in the 2-linear chain and that it grew with distance from the sulfur atom until it became equipotent to 2-n-hexylthiohypoxanthine. Enzymatic oxidation on C(2) occurred in the 8-alkylthiohypoxanthines. On the contrary, oxidation on C(8) did not occur in the 2-alkythioderivatives, demonstrating that the chain forced these molecules to form a complex with molybdenum(VI) involving only the N(3) and N(9) nitrogen atoms.
European Journal of Medicinal Chemistry | 2003
Giuliana Biagi; Irene Giorgi; Michele Leonardi; Oreste Livi; Federica Pacchini; Valerio Scartoni; Barbara Costa; Antonio Lucacchini
In this paper we describe synthesis and biological assays of some A(1) ligands more water-soluble than the effective, but very lipophilic, 8-azaadenines and adenines discovered in the past and obtained introducing on N(6) or N(9) substituent a hydroxy group. Five of the new N(6)-hydroxyalkyl- and N(6)-hydroxycycloalkyl-2-phenyl-9-benzyl-8-azaadenines showed very high affinity (Ki<40 nM) and selectivity for A(1) adenosine receptors. Among the 2-phenyl-9-(2-hydroxy-3-alkyl)-8-azaadenines or adenines prepared, the compounds with the higher A(1) affinity and selectivity resulted 2-phenyl-9-(2-hydroxy-3-propyl)-N(6)-cyclopentyl- and cyclohexyl-8-azaadenine with Ki 2.2+/-0.2 nM and 2.8+/-0.3 nM respectively. From the point of view of water-solubility, 2-phenyl-9-(2-hydroxy-3-propyl)-8-azaadenine was the most interesting compound, having a CLogP of 1.066991 and a water-solubility of 1.2 mg mL(-1).
Farmaco | 2001
Giuliana Biagi; Irene Giorgi; Federica Pacchini; Oreste Livi; Valerio Scartoni
Synthesis of a series of new 2-phenyl-9-benzyl-8-azaadenines bearing on N6 an alkyl or aralkyl chain having a carbonyloxymethyl group on the carbon bound to N6 were reported. The ester group could assure to the molecule a better water-solubility than the 8-azaadenines 2, 6 and 9 substituted with lipophilic groups synthesised in the past. Compounds synthesised demonstrated only little capability of binding A1 adenosine receptors.
European Journal of Medicinal Chemistry | 2003
Giuliana Biagi; Irene Giorgi; Oreste Livi; Antonio Nardi; Federica Pacchini; Valerio Scartoni; Antonio Lucacchini
Bioorganic & Medicinal Chemistry | 2005
Giuliana Biagi; Anna Maria Bianucci; Alessio Coi; Barbara Costa; Laura Fabbrini; Irene Giorgi; Oreste Livi; Iolanda Micco; Federica Pacchini; Edoardo Santini; Michele Leonardi; Fatena Ahmad Nofal; Oreste LeRoy Salerni; Valerio Scartoni
Drug Development Research | 2001
A. Maria Bianucci; Giuliana Biagi; Alessio Coi; Irene Giorgi; Livi Oreste; Federica Pacchini; Valerio Scartoni; Antonio Lucacchini; Barbara Costa
Journal of Heterocyclic Chemistry | 2002
Giuliana Biagi; Irene Giorgi; Oreste Livi; Federica Pacchini; Valerio Scartoni
Journal of Heterocyclic Chemistry | 2004
Giuliana Biagi; Irene Giorgi; Oreste Livi; Federica Pacchini; Valerio Scartoni; Oreste LeRoy Salerni
Journal of Heterocyclic Chemistry | 2005
Giuliana Biagi; Irene Giorgi; Oreste Livi; Federica Pacchini; Valerio Scartoni; Oreste LeRoy Salerni